Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MyBONE
- Development stage
- Phase 4
- Lead developer
- Docventures
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
MyBONE is an oral nutritional supplement developed and marketed by Docventures Pharmaceuticals Pvt Ltd. It is a fixed-dose combination product containing calcium carbonate (500 mg) and vitamin D3 (cholecalciferol, 250 IU). The supplement is indicated for the treatment and prevention of calcium and vitamin D deficiencies, and is prescribed for the management of bone-related conditions such as osteoporosis, rickets, osteomalacia, and hypoparathyroidism. Calcium carbonate provides elemental calcium essential for bone mineralization and structural integrity, while vitamin D3 acts as an agonist at the vitamin D receptor (VDR) to enhance intestinal calcium absorption and maintain phosphate homeostasis.
- Brand names
- MyBONE
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on MyBONE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MyBONE.